Phase I/II clinical trial of high-dose [<sup>131</sup>I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation

Added 56 days ago (28.11.2021)
Authors: Rie Kuroda; Hiroshi Wakabayashi; Raita Araki; Anri Inaki; Ryosei Nishimura; Yasuhiro Ikawa; Kenichi Yoshimura; Toshinori Murayama; Yasuhito Imai; Tatsuyoshi Funasaka; Taizo Wada; Seigo Kinuya
Read article